United States· US:10122-510_6b713a41-2648-43f4-9a10-cc41a7e83ca0
Curosurf
A medicinal product containing poractant alfa, registered in United States by Chiesi USA, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PORACTANT ALFA
- Manufacturer
- Chiesi USA, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1110122510011.5 mL in 1 VIAL, GLASS (10122-510-01)
- ndc1110122510033 mL in 1 VIAL, GLASS (10122-510-03)
- ndc1110122-510-01
- ndc1110122-510-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Poractant alfa in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCurosurfChiesi Farmaceutici S.p.A.
- SwedenCurosurf 80 mg/ml Instillationsvätska för luftvägarna, suspensionOrifarm AB
- United KingdomCurosurf 120mg/1.5ml endotracheopulmonary suspension vialsChiesi Ltd
- FranceCUROSURF 120 mg/1,5 ml, suspension pour instillation endotrachéobronchiqueCHIESI
- IrelandCUROSURF 120 mg/vial Endotracheopulmonary instillation, suspensionChiesi Farmaceutici S.p.A.
- PolandCurosurfDelfarma Sp. z o.o.
- NorwayCurosurfChiesi Farmaceutici S.p.a.
- CanadaCUROSURFCHIESI FARMACEUTICI S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Curosurf
- Belgium · Curosurf
- Bulgaria · Куросърф
- Cyprus · Curosurf
- Czechia · Curosurf
- Denmark · Curosurf
- Estonia · Curosurf
- Spain · Curosurf
- Finland · Curosurf
- France · Curosurf
- United Kingdom (Northern Ireland) · Curosurf
- Greece · Curosurf
- Croatia · Curosurf
- Hungary · Curosurf
- Ireland · Curosurf
- Iceland · Curosurf
- Italy · Curosurf
- Lithuania · Curosurf
- Luxembourg · Curosurf
- Latvia · Curosurf
- Malta · Curosurf
- Netherlands · Curosurf
- Norway · Curosurf
- Poland · Curosurf
- Portugal · Curosurf
- Romania · Curosurf
- Sweden · Curosurf
- Slovenia · Curosurf
- Slovakia · Curosurf
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5df20b29-ca75-4180-aeb4-e7f91daae215 GET /v1/drugs/5df20b29-ca75-4180-aeb4-e7f91daae215?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ENDOTRACHEAL",
"source": "ndc",
"strength": "80",
"substance": "PORACTANT ALFA",
"productndc": "10122-510",
"dosage_form": "SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA020744",
"marketing_category": "BLA"
}See everything about poractant alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.